CD4 and neoplasm: Factors which might influence the differentiation of Tregs are particularly important in the outcome of tumor immunotherapy, as these cells affect all aspects of anti-tumor response including monocyte/macrophage differentiation, antigen presentation and CD4/CD8 T cell activity.